Stay updated on Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, and API users can provide input before this change. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has added new sections on Immunologic Factors, Physiological Effects of Drugs, and Antibodies, Monoclonal, enhancing its core content significantly.SummaryDifference0.3%
- Check46 days agoChange DetectedThe webpage has undergone significant updates, including the addition of a new study on Metastatic Colorectal Cancer (mCRC) and the revision of the study version to v2.15.0. Key collaborators have been specified, and some previous content has been removed, indicating a shift in focus or details regarding the clinical study.SummaryDifference51%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check82 days agoChange DetectedThe page has been updated to include new sections on Immunologic Factors, Physiological Effects of Drugs, and Antibodies, Monoclonal.SummaryDifference0.3%
Stay in the know with updates to Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.